Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Locally Recurrent”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)UnknownNCT00005869
What this trial is testing

Nitrocamptothecin Compared With Gemcitabine in Treating Patients With Unresectable Locally Advanced or Metastatic Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Astex Pharmaceuticals, Inc.
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07214142
What this trial is testing

Total Neoadjuvant Therapy With PD-1 for Locally Advcancer Rectal Cancer

Who this might be right for
Rectal Cancer Patients
The First Affiliated Hospital of University of Science and Technology of China 30
Testing effectiveness (Phase 2)Study completedNCT00073983
What this trial is testing

Gemcitabine and Docetaxel in Treating Patients With Recurrent Osteosarcoma (Closed to Accrual as of 12/21/06) or Ewing's Sarcoma or Unresectable or Locally Recurrent Chondrosarcoma

Who this might be right for
Sarcoma
Sarcoma Alliance for Research through Collaboration 54
Testing effectiveness (Phase 2)Study completedNCT00033540
What this trial is testing

S0202 Gemcitabine and Capecitabine for Unresectable Locally Advanced Metastatic Gallbladder Cancer or Cholangiocarcinoma

Who this might be right for
Extrahepatic Bile Duct CancerGallbladder Cancer
SWOG Cancer Research Network 57
Testing effectiveness (Phase 2)Study completedNCT00376688
What this trial is testing

Temsirolimus in Treating Patients With Locally Advanced or Metastatic Breast Cancer

Who this might be right for
Recurrent Breast CarcinomaStage III Breast Cancer AJCC v7Stage IIIA Breast Cancer AJCC v7+3 more
National Cancer Institute (NCI) 31
Testing effectiveness (Phase 2)Study completedNCT01082211
What this trial is testing

Radiation Therapy in Treating Women With Locally Recurrent Breast Cancer Previously Treated With Repeat Breast-Preserving Surgery

Who this might be right for
Breast Cancer
Radiation Therapy Oncology Group 65
Testing effectiveness (Phase 2)Looking for participantsNCT06962865
What this trial is testing

A Phase Ⅱ Study of RC108 in Combination With Furmonertinib for the First-line Treatment of EGFR-Mutated Combined MET-Positive Unresectable Locally Advanced or Recurrent Metastatic NSCLC

Who this might be right for
Non-Small Cell Lung Cancer
RemeGen Co., Ltd. 80
Testing effectiveness (Phase 2)UnknownNCT00033709
What this trial is testing

Temozolomide and Thalidomide in Treating Patients With Metastatic, Locally Advanced, or Unresectable Leiomyosarcoma

Who this might be right for
Sarcoma
Herbert Irving Comprehensive Cancer Center
Testing effectiveness (Phase 2)Study completedNCT00003428
What this trial is testing

Hormone Therapy in Treating Women With Breast Cancer

Who this might be right for
Breast Cancer
Memorial Sloan Kettering Cancer Center 114
Early research (Phase 1)Ended earlyNCT00005067
What this trial is testing

Photodynamic Therapy With Lutetium Texaphyrin in Treating Patients With Locally Recurrent Prostate Cancer

Who this might be right for
Adenocarcinoma of the ProstateRecurrent Prostate CancerStage I Prostate Cancer+2 more
National Cancer Institute (NCI) 24
Testing effectiveness (Phase 2)Study completedNCT01740336
What this trial is testing

Paclitaxel With GDC-0941 Versus Paclitaxel With Placebo in Participants With Locally Recurrent or Metastatic Breast Cancer

Who this might be right for
Breast Cancer
Genentech, Inc. 183
Large-scale testing (Phase 3)Study completedNCT04540211
What this trial is testing

Atezolizumab Plus Tiragolumab in Combination With Paclitaxel and Cisplatin Compared With Paclitaxel and Cisplatin as First-Line Treatment in Participants With Unresectable Locally Advanced, Unresectable Recurrent, or Metastatic Esophageal Carcinoma

Who this might be right for
Esophageal Cancer
Hoffmann-La Roche 461
Early research (Phase 1)Study completedNCT01291407
What this trial is testing

A Phase I Study of S-1 in Combination With Radiotherapy in Locally Advanced or Recurrent Gastric Cancer

Who this might be right for
Gastrointestinal NeoplasmsGastric Cancer
Chinese Academy of Medical Sciences 27
Testing effectiveness (Phase 2)Looking for participantsNCT06051695
What this trial is testing

Evaluate the Safety and Efficacy of Mesothelin-Targeting Logic-gated CAR T, in Participants With Solid Tumors That Express MSLN and Have Lost HLA-A*02 Expression

Who this might be right for
Solid Tumor, AdultColorectal CancerNSCLC+17 more
A2 Biotherapeutics Inc. 474
Testing effectiveness (Phase 2)UnknownNCT00851916
What this trial is testing

CyberKnife Radiosurgery for Locally Recurrent Prostate CA

Who this might be right for
Recurrent Prostate Cancer
CyberKnife Centers of San Diego 20
Large-scale testing (Phase 3)Looking for participantsNCT07111832
What this trial is testing

A Clinical Trial of SHR-A1811 in the Treatment of Triple-negative Breast Cancer

Who this might be right for
PD-L1-positive Locally Recurrent Unresectable or Metastatic Triple-negative Breast Cancer
Suzhou Suncadia Biopharmaceuticals Co., Ltd. 400
Large-scale testing (Phase 3)Looking for participantsNCT06103864
What this trial is testing

A Phase III Study of Dato-DXd With or Without Durvalumab Compared With Investigator's Choice of Chemotherapy in Combination With Pembrolizumab in Patients With PD-L1 Positive Locally Recurrent Inoperable or Metastatic Triple-negative Breast Cancer (TROPION-Breast05)

Who this might be right for
Breast Cancer
AstraZeneca 625
Testing effectiveness (Phase 2)Looking for participantsNCT06928584
What this trial is testing

Hypofractionated Radiotherapy Plus Immunotherapy Versus Conventional Radiotherapy in Locally Recurrent Rectal Cancer

Who this might be right for
Locally Recurrent Rectal Cancer
Fudan University 221
Not applicableStudy completedNCT06195254
What this trial is testing

Stereotactic Body Radiotherapy Combined With PD-1 Blockers for Locally Advanced or Locally Recurrent Pancreatic Cancer

Who this might be right for
Stereotactic Body RadiotherapyPD-1 InhibitorsPancreatic Cancer
Peking University Third Hospital 19
Large-scale testing (Phase 3)Study completedNCT00088894
What this trial is testing

Gemcitabine With or Without Bevacizumab in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer

Who this might be right for
Adenocarcinoma of the PancreasRecurrent Pancreatic CancerStage II Pancreatic Cancer+2 more
National Cancer Institute (NCI) 590
Next Page